294 related articles for article (PubMed ID: 36982569)
1. Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.
Fujiwara-Tani R; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Kondoh M; Kuniyasu H
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982569
[TBL] [Abstract][Full Text] [Related]
2. C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin.
Gao Z; Xu X; McClane B; Zeng Q; Litkouhi B; Welch WR; Berkowitz RS; Mok SC; Garner EI
Clin Cancer Res; 2011 Mar; 17(5):1065-74. PubMed ID: 21123456
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells.
Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N
Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326
[TBL] [Abstract][Full Text] [Related]
4. Role of
Fujiwara-Tani R; Fujii K; Mori S; Kishi S; Sasaki T; Ohmori H; Nakashima C; Kawahara I; Nishiguchi Y; Mori T; Sho M; Kondoh M; Luo Y; Kuniyasu H
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481659
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of
Maesaka F; Kuwada M; Horii S; Kishi S; Fujiwara-Tani R; Mori S; Fujii K; Mori T; Ohmori H; Owari T; Miyake M; Nakai Y; Tanaka N; Bhawal UK; Luo Y; Kondoh M; Fujimoto K; Kuniyasu H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742959
[TBL] [Abstract][Full Text] [Related]
6. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
[TBL] [Abstract][Full Text] [Related]
7. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
Uthayanan L; El-Bahrawy M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
[TBL] [Abstract][Full Text] [Related]
8. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
Shang X; Lin X; Manorek G; Howell SB
Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.
Lin X; Shang X; Manorek G; Howell SB
PLoS One; 2013; 8(6):e67496. PubMed ID: 23805314
[TBL] [Abstract][Full Text] [Related]
10. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.
Shang X; Lin X; Alvarez E; Manorek G; Howell SB
Neoplasia; 2012 Oct; 14(10):974-85. PubMed ID: 23097631
[TBL] [Abstract][Full Text] [Related]
11. Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin.
Piontek A; Eichner M; Zwanziger D; Beier LS; Protze J; Walther W; Theurer S; Schmid KW; Führer-Sakel D; Piontek J; Krause G
Mol Oncol; 2020 Feb; 14(2):261-276. PubMed ID: 31825142
[TBL] [Abstract][Full Text] [Related]
12. Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.
Gabig TG; Waltzer WC; Whyard T; Romanov V
Biochem Biophys Res Commun; 2016 Sep; 478(2):887-92. PubMed ID: 27520378
[TBL] [Abstract][Full Text] [Related]
13. Role of Nuclear Claudin-4 in Renal Cell Carcinoma.
Owari T; Sasaki T; Fujii K; Fujiwara-Tani R; Kishi S; Mori S; Mori T; Goto K; Kawahara I; Nakai Y; Miyake M; Luo Y; Tanaka N; Kondoh M; Fujimoto K; Kuniyasu H
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172177
[TBL] [Abstract][Full Text] [Related]
14. Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma.
Kwon MJ; Kim SH; Jeong HM; Jung HS; Kim SS; Lee JE; Gye MC; Erkin OC; Koh SS; Choi YL; Park CK; Shin YK
Lab Invest; 2011 Nov; 91(11):1652-67. PubMed ID: 21844869
[TBL] [Abstract][Full Text] [Related]
15. A claudin 3 and claudin 4-targeted Clostridium perfringens protoxin is selectively cytotoxic to PSA-producing prostate cancer cells.
Romanov V; Whyard TC; Waltzer WC; Gabig TG
Cancer Lett; 2014 Sep; 351(2):260-4. PubMed ID: 24952257
[TBL] [Abstract][Full Text] [Related]
16. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier.
Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S
J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866
[TBL] [Abstract][Full Text] [Related]
17. Prolactin and glucocorticoid signaling induces lactation-specific tight junctions concurrent with β-casein expression in mammary epithelial cells.
Kobayashi K; Tsugami Y; Matsunaga K; Oyama S; Kuki C; Kumura H
Biochim Biophys Acta; 2016 Aug; 1863(8):2006-16. PubMed ID: 27130254
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines.
Ogawa M; Kojima T; Someya M; Nomura K; Takasawa A; Murata M; Tanaka S; Saito T; Sawada N
Histochem Cell Biol; 2012 Aug; 138(2):323-38. PubMed ID: 22544349
[TBL] [Abstract][Full Text] [Related]
19. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.
Litkouhi B; Kwong J; Lo CM; Smedley JG; McClane BA; Aponte M; Gao Z; Sarno JL; Hinners J; Welch WR; Berkowitz RS; Mok SC; Garner EI
Neoplasia; 2007 Apr; 9(4):304-14. PubMed ID: 17460774
[TBL] [Abstract][Full Text] [Related]
20. Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors.
Yuan X; Lin X; Manorek G; Kanatani I; Cheung LH; Rosenblum MG; Howell SB
Mol Cancer Ther; 2009 Jul; 8(7):1906-15. PubMed ID: 19567823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
